Mostrando 3 resultados de: 3
A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
ArticleAbstract: Background: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as aPalabras claves:Autores:Lahera V., Márquez G.A., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P., Rueda-Clausen C.F., Silva-Sieger F.A.Fuentes:googlescopusDetermination of Insulin Resistance Using the Homeostatic Model Assessment (HOMA) and its Relation With the Risk of Developing Pregnancy-Induced Hypertension
ArticleAbstract: Objective: To assess whether increased insulin resistance determined by homeostatic model assessmentPalabras claves:HOMA, Insulin Resistance, Metabolic syndrome, pregnancy-induced hypertensionAutores:Arenas-Mantilla M., Camacho-López P.A., Celedón J., García-Gómez R.G., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P., Sierra-Laguado J.Fuentes:googlescopusSocioeconomic pathology as a cause of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension
ReviewAbstract: The epidemic of cardiovascular desease being experienced by developing countries has resulted in a dPalabras claves:Cardiovascular disease, Metabolic syndrome, pregnancy-induced hypertension, Social inequality, Socioeconomic pathologyAutores:Castillo V.R., Lahera V., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P.Fuentes:googlescopus